Cargando…

A Novel Interaction between Tryptophan Hydroxylase 2 (TPH2) Gene Polymorphism (rs4570625) and BDNF Val(66)Met Predicts a High-Risk Emotional Phenotype in Healthy Subjects

Poor inhibitory processing of negative emotional content is central to many psychiatric disorders, including depression and anxiety. Moreover, increasing evidence suggests that core aspects of emotion-inhibitory processing are largely inherited and as such may represent a key intermediate or risk-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Latsko, Maeson S., Gilman, T. Lee, Matt, Lindsey M., Nylocks, K. Maria, Coifman, Karin G., Jasnow, Aaron M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047464/
https://www.ncbi.nlm.nih.gov/pubmed/27695066
http://dx.doi.org/10.1371/journal.pone.0162585
_version_ 1782457419769577472
author Latsko, Maeson S.
Gilman, T. Lee
Matt, Lindsey M.
Nylocks, K. Maria
Coifman, Karin G.
Jasnow, Aaron M.
author_facet Latsko, Maeson S.
Gilman, T. Lee
Matt, Lindsey M.
Nylocks, K. Maria
Coifman, Karin G.
Jasnow, Aaron M.
author_sort Latsko, Maeson S.
collection PubMed
description Poor inhibitory processing of negative emotional content is central to many psychiatric disorders, including depression and anxiety. Moreover, increasing evidence suggests that core aspects of emotion-inhibitory processing are largely inherited and as such may represent a key intermediate or risk-related phenotype for common affective diseases (e.g., unipolar depressive, anxiety disorders). The current study employed a candidate-gene approach in order to most effectively examine this complex behavioral phenotype. We examined the novel interaction between BDNF (Val(66)Met) and TPH2 (rs4570625) polymorphisms and their influence on behavioral inhibition of negative emotion in two independent investigations of healthy adults. BDNF Met carriers consistently report greater symptoms of affective disease and display corresponding behavioral rigidity, while TPH2 T carriers display poor inhibitory processing. These genotypes are traditionally perceived as ‘risk’ genotypes when compared to their respective major Val and G homozygous genotypes, but evidence is mixed. Recent studies in humans and mutant mouse models suggest biological epistasis between BDNF and genes involved in serotonin regulation. Moreover, polymorphisms in the TPH2 gene may have greater influence on serotonergic function than other more commonly studied polymorphisms (e.g., 5-HTTLPR). We observed consistent evidence across two different emotion-inhibition paradigms, one with high internal validity (Study 1, n = 119) and one with high ecological validity (Study 2, n = 115) that the combination of Val/Val and G/G genotypes was clearly associated with impaired inhibition of negative emotional content. This was followed by individuals carrying the BDNF—Met allele (including Met/Val and Met/Met) when combined with the TPH2—T allele (including T/G and T/T combinations). The consistency of these results across tasks and studies suggests that these two groups may be particularly vulnerable to the most common psychiatric disorders and should be targets for future clinical investigation.
format Online
Article
Text
id pubmed-5047464
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50474642016-10-27 A Novel Interaction between Tryptophan Hydroxylase 2 (TPH2) Gene Polymorphism (rs4570625) and BDNF Val(66)Met Predicts a High-Risk Emotional Phenotype in Healthy Subjects Latsko, Maeson S. Gilman, T. Lee Matt, Lindsey M. Nylocks, K. Maria Coifman, Karin G. Jasnow, Aaron M. PLoS One Research Article Poor inhibitory processing of negative emotional content is central to many psychiatric disorders, including depression and anxiety. Moreover, increasing evidence suggests that core aspects of emotion-inhibitory processing are largely inherited and as such may represent a key intermediate or risk-related phenotype for common affective diseases (e.g., unipolar depressive, anxiety disorders). The current study employed a candidate-gene approach in order to most effectively examine this complex behavioral phenotype. We examined the novel interaction between BDNF (Val(66)Met) and TPH2 (rs4570625) polymorphisms and their influence on behavioral inhibition of negative emotion in two independent investigations of healthy adults. BDNF Met carriers consistently report greater symptoms of affective disease and display corresponding behavioral rigidity, while TPH2 T carriers display poor inhibitory processing. These genotypes are traditionally perceived as ‘risk’ genotypes when compared to their respective major Val and G homozygous genotypes, but evidence is mixed. Recent studies in humans and mutant mouse models suggest biological epistasis between BDNF and genes involved in serotonin regulation. Moreover, polymorphisms in the TPH2 gene may have greater influence on serotonergic function than other more commonly studied polymorphisms (e.g., 5-HTTLPR). We observed consistent evidence across two different emotion-inhibition paradigms, one with high internal validity (Study 1, n = 119) and one with high ecological validity (Study 2, n = 115) that the combination of Val/Val and G/G genotypes was clearly associated with impaired inhibition of negative emotional content. This was followed by individuals carrying the BDNF—Met allele (including Met/Val and Met/Met) when combined with the TPH2—T allele (including T/G and T/T combinations). The consistency of these results across tasks and studies suggests that these two groups may be particularly vulnerable to the most common psychiatric disorders and should be targets for future clinical investigation. Public Library of Science 2016-10-03 /pmc/articles/PMC5047464/ /pubmed/27695066 http://dx.doi.org/10.1371/journal.pone.0162585 Text en © 2016 Latsko et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Latsko, Maeson S.
Gilman, T. Lee
Matt, Lindsey M.
Nylocks, K. Maria
Coifman, Karin G.
Jasnow, Aaron M.
A Novel Interaction between Tryptophan Hydroxylase 2 (TPH2) Gene Polymorphism (rs4570625) and BDNF Val(66)Met Predicts a High-Risk Emotional Phenotype in Healthy Subjects
title A Novel Interaction between Tryptophan Hydroxylase 2 (TPH2) Gene Polymorphism (rs4570625) and BDNF Val(66)Met Predicts a High-Risk Emotional Phenotype in Healthy Subjects
title_full A Novel Interaction between Tryptophan Hydroxylase 2 (TPH2) Gene Polymorphism (rs4570625) and BDNF Val(66)Met Predicts a High-Risk Emotional Phenotype in Healthy Subjects
title_fullStr A Novel Interaction between Tryptophan Hydroxylase 2 (TPH2) Gene Polymorphism (rs4570625) and BDNF Val(66)Met Predicts a High-Risk Emotional Phenotype in Healthy Subjects
title_full_unstemmed A Novel Interaction between Tryptophan Hydroxylase 2 (TPH2) Gene Polymorphism (rs4570625) and BDNF Val(66)Met Predicts a High-Risk Emotional Phenotype in Healthy Subjects
title_short A Novel Interaction between Tryptophan Hydroxylase 2 (TPH2) Gene Polymorphism (rs4570625) and BDNF Val(66)Met Predicts a High-Risk Emotional Phenotype in Healthy Subjects
title_sort novel interaction between tryptophan hydroxylase 2 (tph2) gene polymorphism (rs4570625) and bdnf val(66)met predicts a high-risk emotional phenotype in healthy subjects
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047464/
https://www.ncbi.nlm.nih.gov/pubmed/27695066
http://dx.doi.org/10.1371/journal.pone.0162585
work_keys_str_mv AT latskomaesons anovelinteractionbetweentryptophanhydroxylase2tph2genepolymorphismrs4570625andbdnfval66metpredictsahighriskemotionalphenotypeinhealthysubjects
AT gilmantlee anovelinteractionbetweentryptophanhydroxylase2tph2genepolymorphismrs4570625andbdnfval66metpredictsahighriskemotionalphenotypeinhealthysubjects
AT mattlindseym anovelinteractionbetweentryptophanhydroxylase2tph2genepolymorphismrs4570625andbdnfval66metpredictsahighriskemotionalphenotypeinhealthysubjects
AT nylockskmaria anovelinteractionbetweentryptophanhydroxylase2tph2genepolymorphismrs4570625andbdnfval66metpredictsahighriskemotionalphenotypeinhealthysubjects
AT coifmankaring anovelinteractionbetweentryptophanhydroxylase2tph2genepolymorphismrs4570625andbdnfval66metpredictsahighriskemotionalphenotypeinhealthysubjects
AT jasnowaaronm anovelinteractionbetweentryptophanhydroxylase2tph2genepolymorphismrs4570625andbdnfval66metpredictsahighriskemotionalphenotypeinhealthysubjects
AT latskomaesons novelinteractionbetweentryptophanhydroxylase2tph2genepolymorphismrs4570625andbdnfval66metpredictsahighriskemotionalphenotypeinhealthysubjects
AT gilmantlee novelinteractionbetweentryptophanhydroxylase2tph2genepolymorphismrs4570625andbdnfval66metpredictsahighriskemotionalphenotypeinhealthysubjects
AT mattlindseym novelinteractionbetweentryptophanhydroxylase2tph2genepolymorphismrs4570625andbdnfval66metpredictsahighriskemotionalphenotypeinhealthysubjects
AT nylockskmaria novelinteractionbetweentryptophanhydroxylase2tph2genepolymorphismrs4570625andbdnfval66metpredictsahighriskemotionalphenotypeinhealthysubjects
AT coifmankaring novelinteractionbetweentryptophanhydroxylase2tph2genepolymorphismrs4570625andbdnfval66metpredictsahighriskemotionalphenotypeinhealthysubjects
AT jasnowaaronm novelinteractionbetweentryptophanhydroxylase2tph2genepolymorphismrs4570625andbdnfval66metpredictsahighriskemotionalphenotypeinhealthysubjects